At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 196 enrolled
Drug / intervention
Voltaren Geldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Real-World Evidence Study Evaluating the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis (OA) Pain
In Brief
A Phase 4 clinical trial evaluating Voltaren Gel for Pain. Completed, enrolled 196 participants across 8 sites in 2 countries.
Detailed Summary
The purpose of this study is to investigate how topical diclofenac use can improve functional mobility and physical activity primarily, as well as other quality-of-life (QoL) parameters such as sleep, mood, and engagement in daily activities in participants with knee OA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesPoland, United States
Collaborators--
Timeline
Phase 4CompletedFinished
20252026
First PostedApr 2024
Enrollment StartApr 2024
Primary CompletionOct 2024
TodayJul 2026
First PostedApr 23, 2024
Enrollment StartApr 25, 2024
Primary CompletionOct 29, 2024
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 2.2 years ago
Interventions
Voltaren Geldrug
Diclofenac sodium gel in 3 different concentrations as- Diclofenac sodium 1%, 1.16% and 2.32% whichever was available in the given region.